Inventor · disambiguated record
Sharon Engel
Also filed as: ENGEL SHARON · ENGEL SHARON R · ENGEL SHARON RAE
13 granted patents·10 pending applications·58 citations·filing 1998–2021
90Inventor score
Top patents by PatentIndex Score
23 records- 0191US8053603B2Tetralone-based monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2006·Granted Nov 8, 2011·24 cites·23 claims
- 0281US9758529B2Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disordersSUNOVION PHARMACEUTICALS INC·Filed 2016·Granted Sep 12, 2017·3 cites·54 claims
- 0378US6783954B2VEGF nucleic acid and amino acid sequencesCOMPUGEN LTD·Filed 2001·Granted Aug 31, 2004·7 cites·8 claims
- 0477US8669291B2Phenyl substituted cycloalkylamines as monoamine reuptake inhibitorsSHAO LIMING·Filed 2008·Granted Mar 11, 2014·2 cites·19 claims
- 0575US6720182B1Alternative splice variants of CD40COMPUGEN LTD CORP·Filed 2000·Granted Apr 13, 2004·5 cites·6 claims
- 0675US6506884B1Variant of vascular endothelial growth factorCOMPUGEN LTD·Filed 2000·Granted Jan 14, 2003·6 cites·6 claims
- 0769US8877975B2Cycloalkylamines as monoamine reuptake inhibitorsSHAO LIMING·Filed 2010·Granted Nov 4, 2014·1 cites·23 claims
- 0869US2021300942A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0966US9586888B2Phenyl substituted cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·0 cites·27 claims
- 1065US9868718B2Cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·0 cites·2 claims
- 1163US2017204050A1Phenyl substituted cycloalkylamines as monoamine reputake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1261US2020024286A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1360US2007203111A1Cycloalkylamines as monoamine reuptake inhibitorsSEPRACOR INC·Filed 2007·Application pending·0 cites
- 1457US10562878B2Cycloalkylamines as monoamine reuptake inhibitorsSUNOVION PHARMACEUTICALS INC·Filed 2017·Granted Feb 18, 2020·0 cites·26 claims
- 1557US6630612B25-HT3 receptor assay using transgenic mammalUNIV NEW MEXICO·Filed 2001·Granted Oct 7, 2003·5 cites·17 claims
- 1656US2018057506A1Fused dihydro-4h-pyrazolo[5,1-c][1,4]oxazinyl compounds and analogs for treating cns disordersSUNOVION PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1755US2003125295A1Novel nucleic acid and amino acid sequencesCOMPUGEN LTD·Filed 2002·Application pending·0 cites
- 1849US2004258681A1Alternative splice variantsCOMPUGEN LTD CORP·Filed 2004·Application pending·0 cites
- 1946US8404670B2Histamine H3 inverse agonists and antagonists and methods of use thereofCHYTIL MILAN·Filed 2011·Granted Mar 26, 2013·0 cites·4 claims
- 2042US2011065694A1Histamine H3 Inverse Agonists and Antagonists and Methods of Use ThereofCHYTIL MILAN·Filed 2010·Application pending·0 cites
- 2142US2012172350A1Histamine h3 inverse agonists and antagonists and methods of use thereofCHYTIL MILAN·Filed 2010·Application pending·0 cites
- 2234US2012077802A1Histamine h3 inverse agonists and antagonists and methods of use thereofCHYTIL MILAN·Filed 2010·Application pending·0 cites
- 2332US6252131B1Transgenic mammal having 5-HT3 transgene overexpression in the CMSUNIV NEW MEXICO·Filed 1998·Granted Jun 26, 2001·5 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →